Blog
7 May, 2026
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a ten-point plan ahead of the meeting of heads of state in Belgium next Thursday […]
5 May, 2026
Our country is establishing itself as a hub for clinical research, thanks to its public healthcare system: in 2025 alone, more than 900 trials were authorised […]
4 May, 2026
A study has revealed similar patterns of non-compliance across different countries and calls into question the actual scope of supervision consalud.es A recent analysis published in […]
30 April, 2026
The initiative aims to speed up the approval of medicines, reduce the administrative burden and boost competitiveness against China consalud.es The US Food and Drug Administration […]
29 April, 2026
Farmaindustria held its Annual General Meeting in Madrid on Thursday, during which the Association’s president warned of the risks and uncertainties affecting the sector due to […]
28 April, 2026
An analysis of the scientific literature reveals how geopolitical competition and R&D models are reshaping drug development and access to healthcare consalud.es Pharmaceutical innovation has established […]
27 April, 2026
The role of applications for new medicines in research and the strategic use of experimental treatments consalud.es The development of investigational drugs is one of the […]
20 April, 2026
A recent study reveals that failures in drug development not only reduce future revenue, but also affect mergers, market value and investor confidence consalud.es The cost […]
17 April, 2026
The regulator is stepping up pressure on the pharmaceutical and scientific industries to improve transparency consalud.es The FDA has sounded the alarm over a lack of […]
16 April, 2026
The development of a new medicine is a long, complex and high-risk process. Every new treatment—from a therapy for diabetes to a drug for a rare […]
14 April, 2026
lavanguardia.com Before finally agreeing to her doctor’s proposal, Cecilia Rodríguez had undergone chemotherapy, radiotherapy and immunotherapy. The cancer she had been living with for six years […]
9 April, 2026
The new FIT solution aims to automate processes, improve decision-making and boost efficiency in clinical development Consalud.es Fortrea has announced the launch of Fortrea Intelligent Technology […]
8 April, 2026
The use of nanoparticles is transforming pharmaceutical formulation, improving bioavailability and the development of targeted therapies. consalud.es The development of new medicines is one of the […]
27 March, 2026
The roll-out of the European Health Data Space marks a new chapter in innovation, research and evidence-based practice redaccionmedica.com The search for scientific evidence and the […]
24 March, 2026
A new report by CRA for the European Federation of Pharmaceutical Industries and Associations (EFPIA) explains what Europeans stand to gain if the region regains competitiveness […]
23 March, 2026
A study warns that less than 10% of plastic packaging is recycled Consalud.es Sustainability has moved beyond being merely a reputational issue to become a structural […]
20 March, 2026
The drug aims to restore the function of the protein that causes motor neuron death, and the new molecule could slow the progression of amyotrophic lateral […]
17 March, 2026
Pharmaceutical innovation is about more than just developing new treatments. Researchers from the Ramón y Cajal and 12 de Octubre hospitals are examining the contribution of […]
11 March, 2026
Partnerships between companies and regulatory authorities are becoming an essential strategy for tackling global challenges. Partnerships between companies and regulatory authorities are becoming an essential strategy […]
6 March, 2026
The Community of Madrid aims to strengthen research excellence, attract talent, and consolidate the region as a national and international benchmark in this field. consalud.es The […]
5 March, 2026
eleconomista.es Twenty years ago, few could have predicted the trajectory that drug research and development would follow in Spain. While the country grappled with the real […]
4 March, 2026
These are the five-year figures estimated by a new study on the economic impact of industry-sponsored clinical research in the EU, published in Frontiers in Economics […]
9 February, 2026
An artificial intelligence model trained solely on mammography images demonstrates greater accuracy than breast density in estimating five-year breast cancer risk, paving the way for more […]
5 February, 2026
elglobalfarma.com The global pharmaceutical industry is undergoing a quiet but profound transformation in the way it anticipates the future. A new report on forecasting and artificial […]
3 February, 2026
The project, promoted by the Spanish Society of Hospital Pharmacy, the General Council of Pharmacists, and Farmaindustria, has won the award for Best Pharmaceutical Initiative at […]
29 January, 2026
Although AI has not yet achieved major medical advances on its own, the industry already uses it to save time and costs and speed up trials. […]
27 January, 2026
Both entities are committed to promoting activities that raise awareness of patient associations in Spain, with a special focus on organizations linked to oncology. Begoña Barragán, […]
27 January, 2026
Both regulatory agencies recognize the potential of this technology to transform biomedical innovation and hope to help lay the groundwork for joint work among stakeholders in […]
20 January, 2026
Our country authorized 962 studies last year, a hundred more than in 2023. Four out of every 10 research projects were dedicated to finding new cancer […]
14 January, 2026
The Spanish Registry of Clinical Studies points out that the country’s excellent hospital network and regulatory efficiency make it a strategic destination for the development of […]




























